Enliven Therapeutics Financial Overview
Enliven Therapeutics's market cap is currently $1.20B. The company's EPS TTM is $-0.32; its P/E ratio is ―; Enliven Therapeutics is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is $-0.37. See an overview of income statement, balance sheet, and cash flow financials.
